In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.
about
The life and times of the EnterococcusManagement of multidrug-resistant enterococcal infectionsEndocarditis due to high-level gentamicin-resistant Enterococcus faecalisSynergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycin.Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci.Daptomycin: a review 4 years after first approval.Plasmid-encoded fosfomycin resistanceFosfomycin: an old, new friend?Screening and treatment of infections caused by resistant enterococci.Therapeutic options for vancomycin-resistant enterococcal bacteremia.Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: an overview of epidemiology, management, and prevention.Periprosthetic joint infections: clinical and bench research.In vitro evaluation of high-level, gentamicin-resistant enterococci isolated from bacteremic patients.Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model.
P2860
Q24616875-BC54F0BA-2A77-44F7-A32C-893B411BF174Q28285907-D78C4022-C042-4123-A652-B6B0AE9EC82DQ28368076-423AAC6D-269A-4297-ACED-2A8D47A97982Q33534711-7D7B9083-5C25-4B61-9A0A-323075A544B9Q33745963-2A036A4F-600D-4562-A670-00BC7851FC97Q35110775-4861C4A4-3E93-4BB4-9E4D-A8CFD49B5A88Q36757804-7A2CB870-80D3-430B-BCFB-EEFFDE9E517AQ36972980-FD1136C6-2BC0-4B24-8E4A-5D3EB856D9D4Q37187074-E691C663-26A9-4808-B58C-63D156F522F9Q37633415-35E76AE3-763F-424B-BA75-A1CBB193690EQ37711795-E95D5CF1-01BC-4DC3-8DB5-AFA48E1E1300Q38347869-BEE80E7F-08BB-428A-BE31-FD6B207150C0Q39874965-4EA1963A-1626-4BD6-9654-C31D6AC3A9ADQ42693471-73BEF228-80B5-4868-BE84-E683E9D62C52Q49446863-8315EB65-C068-4A84-8693-F18C3AE64BB7Q53663173-B2D3AD78-F042-46C0-8330-32E1DA468383Q54218755-356F428C-6B0E-40E1-B0E1-35C4C7D2683CQ54284517-0371D335-817A-45B4-96BB-39CCEB95F9FC
P2860
In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
In vitro synergism between dap ...... h-level gentamicin resistance.
@en
In vitro synergism between dap ...... h-level gentamicin resistance.
@nl
type
label
In vitro synergism between dap ...... h-level gentamicin resistance.
@en
In vitro synergism between dap ...... h-level gentamicin resistance.
@nl
prefLabel
In vitro synergism between dap ...... h-level gentamicin resistance.
@en
In vitro synergism between dap ...... h-level gentamicin resistance.
@nl
P2093
P2860
P356
P1476
In vitro synergism between dap ...... h-level gentamicin resistance.
@en
P2093
Eliopoulos GM
Moellering RC Jr
P2860
P304
P356
10.1128/AAC.33.4.470
P407
P577
1989-04-01T00:00:00Z